Dermatologists deal with cosmetic competition
Best defense against unqualified injectors’ discounts involves patient education
National report — With “discount” injectable treatments here to stay, experts say, dermatologists must court sophisticated consumers willing to pay for the quality and expertise that only dermatologists and other core aesthetic specialists offer.
The problem of heavily discounted injectables dates back to unit pricing of neuromodulators and laser package deals, says Vic Narurkar, M.D. In the latter area, he says, “If someone only needs two treatments to get the desired results, selling them a package of five or six is unethical.” Dr. Narurkar is founder and director of the Bay Area Laser Institute, chairman of dermatology at California Pacific Medical Center, San Francisco, and a co-founder of Cosmetic Bootcamp.
John E. Gross, M.D., president of the Physicians Coalition for Injectable Safety (PCIS), adds that low-priced imported or otherwise illicit neuromodulators have been available to U.S. physicians for more than a decade.
“When the economy slid in 2007 to 2008, that encouraged many healthcare providers — including non-core specialists — to look for ways to augment their income,” Dr. Gross says.
The Affordable Care Act further spurred healthcare providers of all stripes to pursue cash-based aesthetic business — and perhaps cut corners, says Dr. Gross, who is also a plastic surgeon based in Pasadena, Calif.
As a result, says Jeanine Downie, M.D., non-core providers ranging from family doctors and OB/GYN's to “medispas that barely have a medical director over them are purchasing fillers and neuromodulators online and marketing them as the real thing. This cheapens our whole marketplace. People come in saying, ‘Dr. So-and-So is selling Botox (onabotulinumtoxinA, Allergan) for $5 a unit’ and expecting you to meet or beat the price.” She is a dermatologist in private practice in Montclair, N.J.
Economically, Dr. Downie says, “I call it a race to the bottom. Non-core competitors try to manipulate all the cosmetic dermatologists into decreasing our prices. And we cannot and should not. We need to maintain that we are board-certified and trained in all aspects of cosmetic and general dermatology; that we are the skincare experts. As a specialty, we should hold ourselves up as the skincare specialists that we are, and therefore should charge a premium for our services.”
MORE ARTICLES IN THIS ISSUE
Leg ulcers are a common and difficult management problem for all dermatologists. Robert Kirsner, M.D., professor and vice chairman, dermatology, University of Miami Miller School of Medicine, director of the University of Miami Hospital Wound Center, elucidates the diagnosis and management of these challenging skin problems.
Before you can understand why many strategies and services are not appropriate for doctors, you must understand the dynamic of the “Average American,” for whom these products and services are designed.
Since the dawn of smoothened inhibitors, patients with locally advanced and metastatic basal cell carcinoma (BCC) now have a new and effective treatment alternative beyond the traditional and less optimal treatment approaches such as surgery and radiotherapy.
Hair disorders are an important concern, especially for African-American women, according to Amy McMichael, M.D., dermatology professor and chairwoman, Wake Forest Baptist Health, Winston-Salem, N.C.
Perceived beauty goes beyond numeric values and divine proportions. In fact, beauty in the beholder’s eyes is a collage of geographic, ethnic and demographic influences, according to research published in the March issue of Journal of Craniofacial Surgery.